ESLA
Price:
$1.93
Market Cap:
$72.89M
Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103 for the treatment of diffuse large B-cell lymphoma and is in pre clinical trial; and EB104 to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia. It has a collaborative partnership with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. is based in EmeryVille, California.
Industry
Biotechnology
IPO Date
2021-09-14
Stock Exchange
NASDAQ
Ticker
ESLA
According to Estrella Immunopharma, Inc.’s latest financial reports and current stock price. The company's current ROE is 686.58%. This represents a change of -381.01% compared to the average of -244.32% of the last 4 quarters.
The mean historical ROE of Estrella Immunopharma, Inc. over the last ten years is -1235.76%. The current 686.58% ROE has changed -155.56% with respect to the historical average. Over the past ten years (40 quarters), ESLA's ROE was at its highest in in the March 2025 quarter at 114.93%. The ROE was at its lowest in in the December 2024 quarter at -730.73%.
Average
-1235.76%
Median
-14.09%
Minimum
-6155.69%
Maximum
162.08%
Discovering the peaks and valleys of Estrella Immunopharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual ROE = 162.08%
Minimum Annual Increase = -108.69%
Minimum Annual ROE = -6155.69%
| Year | ROE | Change |
|---|---|---|
| 2024 | -6155.69% | 3.50% |
| 2024 | -171.09% | 1.11% |
| 2022 | -14.09% | -108.69% |
| 2022 | 162.08% | Infinity% |
The current ROE of Estrella Immunopharma, Inc. (ESLA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2113.62%
5-year avg
-1235.76%
10-year avg
-1235.76%
Estrella Immunopharma, Inc.’s ROE is greater than eXoZymes, Inc. (-127.54%), greater than Greenwich LifeSciences, Inc. (-1042.76%), greater than Atossa Therapeutics, Inc. (-42.83%), greater than Surrozen, Inc. (-180.14%), greater than Anebulo Pharmaceuticals, Inc. (-67.78%), less than Tevogen Bio Holdings Inc. (391.67%), greater than Oncolytics Biotech Inc. (-755.18%), greater than Instil Bio, Inc. (-54.32%), greater than Tiziana Life Sciences Ltd (-125.84%), greater than Immix Biopharma, Inc. (-263.55%),
| Company | ROE | Market cap |
|---|---|---|
| -127.54% | $125.81M | |
| -1042.76% | $121.82M | |
| -42.83% | $98.11M | |
| -180.14% | $156.26M | |
| -67.78% | $97.37M | |
| 391.67% | $83.79M | |
| -755.18% | $98.42M | |
| -54.32% | $77.28M | |
| -125.84% | $98.64M | |
| -263.55% | $162.49M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Estrella Immunopharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Estrella Immunopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Estrella Immunopharma, Inc.'s ROE?
How is the ROE calculated for Estrella Immunopharma, Inc. (ESLA)?
What is the highest ROE for Estrella Immunopharma, Inc. (ESLA)?
What is the 3-year average ROE for Estrella Immunopharma, Inc. (ESLA)?
What is the 5-year average ROE for Estrella Immunopharma, Inc. (ESLA)?
How does the current ROE for Estrella Immunopharma, Inc. (ESLA) compare to its historical average?